FDA Drug Recalls

Recalls / Class II

Class IID-1622-2020

Product

Nature-Throid, 3/4 Grain (48.75 mg) Thyroid U.S.P. 3/4 gr. (48.75 mg)/Liothyronine (T3) 6.75mcg/Levothyroxine (T4) 28.5mcg, 90-count tablets, Rx Only, Mfg: RLC Labs; Cave Creek, AZ, Preferred Pharmaceuticals, Inc. NDC 68788-6860-09

Affected lot / code info
Lot #: B2618E, Exp. Date: 2/28/2021

Why it was recalled

CGMP Deviations

Recalling firm

Firm
Preferred Pharmaceuticals, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1250 N Lakeview Ave Ste O, N/A, Anaheim, California 92807-1801

Distribution

Quantity
N/A
Distribution pattern
Repackaged tablets sold to three physicians located in CA and GA.

Timeline

Recall initiated
2020-09-02
FDA classified
2020-09-24
Posted by FDA
2020-09-30
Terminated
2024-04-25
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1622-2020. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.